Page last updated: 2024-08-24

triazoles and at 13387

triazoles has been researched along with at 13387 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Pillai, RN; Ramalingam, SS1
Agarwal, PK; Hammerich, KH; Hao, JJ; Krane, LS; Li, QQ; Neckers, L; Sanford, T; Trepel, JB; Zhang, Z1
Abbey, YC; Agarwal, S; Alilin, AN; Beshiri, ML; Cawley, J; Corey, E; Fang, L; Fuller, C; Guha, R; Hoover, S; Hynes, PG; Jansson, KH; Kelly, K; Klummp-Thomas, C; Lake, R; McKnight, C; Nguyen, HM; Proia, DA; Simmons, JK; Simpson, RM; Stahl, LE; Thomas, CJ; Tice, CM; Tucker, JB; Yin, J; Zhang, X1
Eshleman, JR; Gulla, A; Kazlauskas, E; Liang, H; Matulis, D; Petrauskas, V; Strupas, K1

Reviews

1 review(s) available for triazoles and at 13387

ArticleYear
Heat shock protein 90 inhibitors in non-small-cell lung cancer.
    Current opinion in oncology, 2014, Volume: 26, Issue:2

    Topics: Benzamides; Benzoquinones; Carcinoma, Non-Small-Cell Lung; HSP90 Heat-Shock Proteins; Humans; Isoindoles; Isoxazoles; Lactams, Macrocyclic; Lung Neoplasms; Molecular Targeted Therapy; Resorcinols; Treatment Outcome; Triazoles

2014

Other Studies

3 other study(ies) available for triazoles and at 13387

ArticleYear
Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics.
    Scientific reports, 2017, 03-15, Volume: 7, Issue:1

    Topics: Antineoplastic Agents; Benzamides; Benzodioxoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 4 or More Rings; Histones; HSP90 Heat-Shock Proteins; Humans; Imidazoles; Isoindoles; Isoxazoles; Protein Processing, Post-Translational; Proteomics; Resorcinols; Triazoles; Urinary Bladder Neoplasms

2017
High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancer.
    Scientific reports, 2018, 11-22, Volume: 8, Issue:1

    Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Genotype; High-Throughput Screening Assays; HSP90 Heat-Shock Proteins; Humans; Isoindoles; Male; Mice; Phenotype; Phosphatidylinositol 3-Kinases; Prostate; Prostatic Neoplasms, Castration-Resistant; PTEN Phosphohydrolase; Signal Transduction; TOR Serine-Threonine Kinases; Triazoles; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2018
Heat Shock Protein 90 Inhibitor Effects on Pancreatic Cancer Cell Cultures.
    Pancreas, 2021, 04-01, Volume: 50, Issue:4

    Topics: Adenosine Triphosphatases; Antineoplastic Agents; Benzamides; Benzoquinones; Carcinoma, Pancreatic Ductal; Cell Culture Techniques, Three Dimensional; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; HSP90 Heat-Shock Proteins; Humans; Isoindoles; Isoxazoles; Lactams, Macrocyclic; Molecular Structure; Pancreatic Neoplasms; Resorcinols; Rifabutin; Triazoles

2021